Effects of estrogen and estrogen-progestin on mammographic parenchymal density

Annals of Internal Medicine

Volumn 130, Issue 4 I, 1999, Pages 262-269

  Greendale, Gail A ^a   Reboussin, Beth A ^b   Sie, Angela ^c   Rosy Singh, H ^d   Olson, Linda K ^e   Gatewood, Olga ^f   Bassett, Lawrence W ^a   Wasilauskas, Carol ^b   Bush, Trudyn ^g   Barrett Connor, Elizabeth ^h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c Radia Medical Imaging   (United States)

^d Advanced Radiology   (United States)

^e UCSD MEDICAL CENTER   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; PLACEBO; PROGESTERONE;

ADULT; ARTICLE; BREAST CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENSITY; DOUBLE BLIND PROCEDURE; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MULTICENTER STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033574030     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-130-4_part_1-199902160-00003     Document Type: Article

References (37)

1. Wolfe JN. Breast patterns as an index of risk for developing breast cancer AJR Am J Roentgenol. 1976;126:1130-7.
2. Brisson J, Sadowsky NL, Twaddle JA, Morrison AS, Cole P, Merletti F. The relation of mammographic features of the breast to breast cancer risk factors, Am J Epidemiol. 1982; 15:438-43.
3. Wolfe JN, Saftlas AF, Salane M. Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. AJR Am J Roentgenol. 1987;148:1087-92.
4. Saftlas AF, Hoover RN, Brinton LA, Szklo M, Olson DR, Salane M, et al. Mammographic densities and risk of breast cancer Cancer. 1991;67: 2833-8.
5. Saftlas AF, Szklo M. Mammographic parenchymal patterns and breast cancer risk. Epidemiol Rev. 1987;9:146-74.
6. Oza AM, Boyd NF. Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol Rev. 1993; 15:196-208.
7. Warner E, Lockwood G, Tritchler D, Boyd NF. The risk of breast cancer associated with mammographic parenchymal patterns: a meta-analysis of the published literature to examine the effect of method of classification. Cancer Detect Prev. 1992;16:67-72.
8. Brisson J, Morrison AS, Khalid N. Mammographic parenchymal features and breast cancer in the breast cancer detection demonstration project. J Natl Cancer Inst. 1988;80:1534-40.
9. Egan RL, Mosteller RC. Breast cancer mammography patterns. Cancer. 1977;40:2087-90.
10. Bergkvist L, Tabar L, Adami HO, Persson I, Bergstrom R. Mammographic parenchymal patterns in women receiving noncontraceptive estrogen treatment. Am J Epidemiol. 1989;130:503-10.
11. Bland KI, Buchanan JB, Weisberg BF, Hagan TA, Gray LA Sr. The effects of exogenous estrogen replacement therapy of the breast: breast cancer risk and mammographic parenchymal pattern. Cancer. 1980;45:3027-33.
12. Berkowitz JE, Gatewood OM, Goldblum LE, Gayler BW. Hormonal replacement therapy: mammographic manifestations. Radiology. 1990; 174: 199-201.
13. McNicholas MM, Heneghan JP, Milner MH, Tunney T, Hourihane JB, MacErlaine DP. Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study, AJR Am J Roentgenol. 1994;163:311-5.
14. Kaufman Z, Garstin WI, Hayes R, Michell MJ, Baum M. The mammographic parenchymal patterns of women on hormonal replacement therapy. Clim Radiol. 1991;43:389-92.
15. Laya MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology. 1995;196:433-7.
16. Stomper PC, Van Voorhis BJ, Ravnikar VA, Meyer JE. Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. Radiology. 1990;174:487-90.
17. Espeland MA, Bush TL, Mebane-Sims I, Stefanick ML, Johnson S, Sherwin R, et al. Rationale, design, and conduct of the PEPI Trial. Postmenopausal Estrogen/Progestin Interventions. Control Clin Trials. 1995;16(Suppl 4): 3S-19S.
18. American College of Radiology. Breast imaging reporting and data system (BI-RADS). 2d ed. Reston, VA: American Coll Radiology; 1995.
19. Spitzer RL, Cohen J, Fleiss JL, Endicott J. Quantification of agreement in psychiatric diagnosis. Arch Gen Psychiatry. 1967;17:83-7.
20. Byng JW, Boyd NF, Little L, Lockwood G, Fishell E, Jong RA, et al. Symmetry of projection in the quantitative analyses of mammographic images. Eur J Cancer Prev. 1996;5:319-27.
21. Zelen M. The analysis of several 2x2 contingency tables. Biometrika. 1971; 58:129-37.
22. Ingleby H, Gershon-Cohen J. Comparative anatomy, pathology and roentgenology of the breast. Philadelphia: Univ of Pennsylvania Pr; 1960.
23. Bartow SA, Pathak DR, Mettler FA. Radiographic microcalcification and parenchymal pattern as indicators of histologic "high-risk" benign breast disease. Cancer. 1990;66:1721-5.
24. Boyd NF, Jensen HM, Cooke G, Han HL. Relationship between mammographic and histological risk factors for breast cancer. J Natl Cancer lnst. 1992;84:1170-9.
25. Urbanski S, Jensen HM, Cooke G, McFarlane D, Shannon P, Kruikov V, et al. The association of histological and radiological indicators of breast cancer risk. Br J Cancer. 1988;58:474-9.
26. Bright RA, Morrison AS, Brisson J, Burstein NA, Sadowsky NS, Kopans DB, et al. Relationship between mammographic and histologic features of breast tissue in women with benign biopsies. Cancer 1988;61:266-71.
27. Bergkvist L, Tabar L. Adami HO, Persson I, Bergstrom R. Mammographic parenchymal patterns in women receiving noncontraceptive estrogen treatment. Am J Epidemiol. 1989;130:503-10.
28. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst. 1995;87:670-5.
29. Bergkvist L, Adami HO, Persson I, Hoover R, Schairer C. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med. 1989;321:293-7.
30. Bergkvist L, Frodis E, Hedborg-Mellander C, Hansen J. Management of accidentally found pathological lymph nodes on routine screening mammography. Eur J Surg Oncol. 1996;22:250-3.
31. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 1995;332:1589-93.
32. Key TJ. Hormones and cancer in humans. Mutat Res. 1995;333:59-67.
33. Michnovicz JJ, Bradlow HL. Dietary and pharmacological control of estradiol metabolism in humans. Ann N Y Acad Sci. 1990;595:291-9.
34. Ginsburg ES, Mello NK, Mendelson JH, Barbieri RL, Teoh SK, Rothman M, et al. Effects of alcohol ingestion on estrogens in postmenopausal women. JAMA. 1996;276:1747-51.
35. Greendale GA, Hogan P, Kritz-Silverstein D, Langer R, Johnson SR, Bush T. Age at menopause in women participating in the postmenopausal estrogen/progestins interventions (PEPI) trial: an example of bias introduced by selection criteria. Menopause. 1995;2:27-34.
36. Boyd NF, Wolfson C, Moskowitz M, Carlisle T, Petitderc C, Ferri HA, et al. Observer variation in the classification of mammographic parenchymal pattern Journal of Chronic Diseases. 1986;39:465-72.
37. Elmore JG, Wells CK, Lee CH, Howard DH, Feinstein AR. Variability in radiologists' interpretations of mammograms. N Engl J Med. 1994;331:1493-9.